| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
March 15, 2006 |
|
|
| |
|
|
| |
|
|
|
Windhover Information, JW Marriott Hotel Washington DC
December 4-5, 2006
Hear the critical trends and changes that affect your regulatory strategy successful strategies for dealing with FDA and CMS
Walk away with practical, real life lessons from some of the most experienced pharmaceutical and biotechnology executives on how they handle regulatory obstacles
Get face-to-face access to the top regulatory thought leaders and policy makers
Hear fresh perspectives on:
• Drug development and NDA approval strategies
• Drug safety, risk management and post-market surveillance
• Biogenerics
• Marketing and promotion regulation and enforcement
• Medicaid and Medicare reimbursement
• Medicare Part D
• Critical Path Initiative
• Pricing Strategies
|
|
|
|
|
|
|
|
Organized by:
|
|
Windhover Information |
|
|
Invited Speakers:
|
|
Top Pharma and Biotech Executive, Regulators from FDA and CMS
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
none
|
|
|
|
|
|
|
|
Registration:
|
|
www.windhover.com
|
|
|
E-mail:
|
|
ariley@windhover.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|